Omlonti® (omidenepag isopropyl) – New drug approval
September 22, 2022 - The FDA approved Santen’s Omlonti (omidenepag isopropyl), for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma (OAG) or ocular hypertension (OT).
Download PDF
